NREP Antibody | CSB-PA050823

(No reviews yet) Write a Review
SKU:
CSB-PA050823
Availability:
3 to 7 Working Days
Size:
100ul
€486.10

Description

NREP Antibody | CSB-PA050823 | Cusabio

NREP Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: NREP

Aliases: Neuronal protein 3.1; Protein p311;

Background: May have roles in neural function. Ectopic expression augments motility of gliomas. Promotes also axonal regeneration By similarity. May also have functions in cellular differentiation By similarity. Induces differentiation of fibroblast into myofibroblast and myofibroblast ameboid migration. Increases retinoic-acid regulation of lipid-droplet biogenesis By similarity. Down-regulates the expression of TGFB1 and TGFB2 but not of TGFB3 By similarity. May play a role in the regulation of alveolar generation.

Tsui S.K.W., Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases.
Studler J.-M.; Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
The MGC Project Team; Genome Res. 14:2121-2127 (2004) .

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: Q16612

Host Species: Rabbit

Species Reactivity: Human, Mouse

Immunogen: Synthesized peptide derived from internal of human C5orf13.

Immunogen Species: Human

Applications: ELISA, IHC

Tested Applications: ELISA, IHC;IHC:1:50-1:100

Purification Method: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Dilution Ratio1: ELISA:1:2000-1:10000

Dilution Ratio2: IHC:1:50-1:100

Dilution Ratio3:

Dilution Ratio4:

Dilution Ratio5:

Dilution Ratio6:

Buffer: Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Form: liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Others

Research Areas: Others

View AllClose

0 Reviews

View AllClose